Literature DB >> 1727199

Plasma cholesterol concentration and mortality. The Whitehall Study.

G D Smith1, M J Shipley, M G Marmot, G Rose.   

Abstract

UNLABELLED: OBJECTIVE--To examine the relationship between plasma cholesterol concentration and mortality from major causes of death.
DESIGN: --Cohort study. SETTING--Civil service offices in London, England. PARTICIPANTS--There were 17,718 male civil servants aged 40 through 64 years at the time of study entry between 1967 and 1969. MAIN OUTCOME MEASURE--Mortality from major cause groups. RESULTS--There were 4022 deaths in the cohort over the 18 years of follow-up. Total mortality increased with cholesterol level, although mortality in the small group with very low cholesterol levels (5% of study population) was nonsignificantly higher (P greater than .5) than that of the remainder of the lowest quintile cholesterol group. Coronary heart disease mortality increased with increasing cholesterol concentration from the lowest levels (P less than .001 for trend). The cancer mortality rate in the group below the fifth centile of the cholesterol distribution was higher than in the remainder of the cohort for lung (P less than .001), pancreas (P = .05), liver (P = .09), and all smoking-related cancers (P = .02). Only for lung cancer was there a consistent inverse trend with cholesterol level (P less than .01). Rates of mortality due to non-neoplastic respiratory disease were inversely related to cholesterol level (P less than .001). Health state at the time of examination and socioeconomic position were related to cholesterol concentration--subjects in lower employment grades, with disease at baseline, with a history of recent unexplained weight loss, or who had been widowed had lower initial cholesterol levels. These associations largely accounted for the relationships between cholesterol level and noncardiovascular mortality. CONCLUSIONS--The inverse associations between plasma cholesterol concentration and mortality from certain causes of death seen in cohort studies could be because the participants with low cholesterol levels possess other characteristics that place them at an elevated risk of death.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727199

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  72 in total

1.  Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study.

Authors:  A Menotti; H Blackburn; D Kromhout; A Nissinen; H Adachi; M Lanti
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Cholesterol and coronary heart disease: screening and treatment.

Authors:  S Ebrahim; G D Smith; C McCabe; N Payne; M Pickin; T A Sheldon; F Lampe; F Sampson; S Ward; G Wannamthee
Journal:  Qual Health Care       Date:  1998-12

3.  Cholesterol levels, statins, vitamin D, and associated risk of pneumonia.

Authors:  Luca Mascitelli; William B Grant; Mark R Goldstein
Journal:  Eur J Clin Pharmacol       Date:  2011-12-15       Impact factor: 2.953

4.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

5.  A model to assess the cost effectiveness of statins in achieving the UK National Service Framework target cholesterol levels.

Authors:  Koo Wilson; John Marriott; Stephen Fuller; Loretto Lacey; David Gillen
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Impaired vasomotor function induced by the combination of hypertension and hypercholesterolemia.

Authors:  Hizir Kurtel; Stephen F Rodrigues; Cigdem E Yilmaz; Alper Yildirim; D Neil Granger
Journal:  J Am Soc Hypertens       Date:  2013 Jan-Feb

7.  Low serum total cholesterol concentrations and mortality in middle aged British men.

Authors:  G Wannamethee; A G Shaper; P H Whincup; M Walker
Journal:  BMJ       Date:  1995-08-12

8.  Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.

Authors:  Z Chen; A Keech; R Collins; B Slavin; J Chen; T C Campbell; R Peto
Journal:  BMJ       Date:  1993-04-03

9.  Associations Between the Serum Metabolome and All-Cause Mortality Among African Americans in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Bing Yu; Gerardo Heiss; Danny Alexander; Morgan E Grams; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2016-03-07       Impact factor: 4.897

10.  Presentation of the rifle project risk factors and life expectancy. The RIFLE Research Group.

Authors: 
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.